These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

98 related items for PubMed ID: 3975630

  • 1. Plasma homovanillic acid concentration and the severity of schizophrenic illness.
    Davis KL, Davidson M, Mohs RC, Kendler KS, Davis BM, Johns CA, DeNigris Y, Horvath TB.
    Science; 1985 Mar 29; 227(4694):1601-2. PubMed ID: 3975630
    [Abstract] [Full Text] [Related]

  • 2. Apomorphine has no effect on plasma homovanillic acid in schizophrenic patients.
    Davidson M, Kendler KS, Davis BM, Horvath TB, Mohs RC, Davis KL.
    Psychiatry Res; 1985 Oct 29; 16(2):95-9. PubMed ID: 3865258
    [Abstract] [Full Text] [Related]

  • 3. Low-dose apomorphine reduces serum homovanillic acid concentrations in schizophrenic patients.
    Cutler NR, Jeste DV, Karoum F, Wyatt RJ.
    Life Sci; 1982 Mar 01; 30(9):753-6. PubMed ID: 7070229
    [Abstract] [Full Text] [Related]

  • 4. Evidence for a daily rhythm of plasma HVA in normal controls but not in schizophrenic patients.
    Doran AR, Pickar D, Labarca R, Douillet P, Wolkowitz OM, Thomas JW, Roy A, Paul SM.
    Psychopharmacol Bull; 1985 Mar 01; 21(3):694-7. PubMed ID: 4034886
    [No Abstract] [Full Text] [Related]

  • 5. Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patients.
    Pickar D, Labarca R, Linnoila M, Roy A, Hommer D, Everett D, Paul SM.
    Science; 1984 Aug 31; 225(4665):954-7. PubMed ID: 6474162
    [Abstract] [Full Text] [Related]

  • 6. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations.
    Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL.
    Arch Gen Psychiatry; 1991 Oct 31; 48(10):910-3. PubMed ID: 1929760
    [Abstract] [Full Text] [Related]

  • 7. Effects of debrisoquin and haloperidol on plasma homovanillic acid concentration in schizophrenic patients.
    Davidson M, Losonczy MF, Mohs RC, Lesser JC, Powchik P, Freed LB, Davis BM, Mykytyn VV, Davis KL.
    Neuropsychopharmacology; 1987 Dec 31; 1(1):17-23. PubMed ID: 3509064
    [Abstract] [Full Text] [Related]

  • 8. Schizophrenia: gender, family risk, and plasma homovanillic acid.
    Dávila R, Zumárraga M, González-Torres MA, Andía I, Zamalloa MI, Basterreche E, Guimón J, Friedhoff AJ.
    Am J Med Genet; 1995 Apr 24; 60(2):154-6. PubMed ID: 7485251
    [Abstract] [Full Text] [Related]

  • 9. Plasma homovanillic acid as a predictor of response to neuroleptics.
    Davila R, Manero E, Zumarraga M, Andia I, Schweitzer JW, Friedhoff AJ.
    Arch Gen Psychiatry; 1988 Jun 24; 45(6):564-7. PubMed ID: 3377643
    [Abstract] [Full Text] [Related]

  • 10. Brain contribution to the haloperidol-induced increase in plasma homovanillic acid.
    Kendler KS, Heninger GR, Roth RH.
    Eur J Pharmacol; 1981 May 08; 71(2-3):321-6. PubMed ID: 7250191
    [Abstract] [Full Text] [Related]

  • 11. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB, Swigar ME, Jatlow PI, Goicoechea N.
    J Clin Psychiatry; 1984 Jun 08; 45(6):248-51. PubMed ID: 6725216
    [Abstract] [Full Text] [Related]

  • 12. Short-term haloperidol administration acutely elevates human plasma homovanillic acid concentration.
    Davidson M, Giordani AB, Mohs RC, Horvath TB, Davis BM, Powchik P, Davis KL.
    Arch Gen Psychiatry; 1987 Feb 08; 44(2):189-90. PubMed ID: 3813816
    [No Abstract] [Full Text] [Related]

  • 13. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
    Magliozzi JR, Doran AR, Gietzen DW, Olson AM, Maclin EL, Tuason VB.
    Psychiatry Res; 1993 May 08; 47(2):141-9. PubMed ID: 8341767
    [Abstract] [Full Text] [Related]

  • 14. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A, Poirier MF, Aymard N, Leyris A, Beauverie P, Bourdel MC, Loo H.
    Acta Psychiatr Scand; 1998 Jun 08; 97(6):458-66. PubMed ID: 9669519
    [Abstract] [Full Text] [Related]

  • 15. Differential effects of haloperidol on negative symptoms in drug-naive schizophrenic patients: effects on plasma homovanillic acid.
    Labarca R, Silva H, Jerez S, Ruiz A, Forray MI, Gysling K, Andres ME, Bustos G, Castillo Y, Hono J.
    Schizophr Res; 1993 Mar 08; 9(1):29-34. PubMed ID: 8461269
    [Abstract] [Full Text] [Related]

  • 16. Effects of haloperidol decanoate on plasma homovanillic acid in chronic schizophrenic patients.
    Chang WH, Lin SK, Juang DJ, Chen LC, Yang CH, Lane HY, Jann MW.
    Biol Psychiatry; 1993 Apr 01; 33(7):557-9. PubMed ID: 8513043
    [No Abstract] [Full Text] [Related]

  • 17. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia.
    Davila R, Gonzalez MA, Zumarraga M, Andia I, Guimon J, Silva RR, Friedhoff AJ.
    Biol Psychiatry; 1995 Aug 15; 38(4):267-9. PubMed ID: 8547450
    [No Abstract] [Full Text] [Related]

  • 18. Sex differences in plasma homovanillic acid in acute psychosis.
    Bowers MB, Swigar ME, Jatlow PI.
    N Engl J Med; 1983 Apr 07; 308(14):845-6. PubMed ID: 6835278
    [No Abstract] [Full Text] [Related]

  • 19. Neuroleptic treatment, symptoms of schizophrenia, and plasma homovanillic acid concentrations revisited.
    Volavka J, Douyon R, Convit A, Czobor P, Cooper TB.
    Arch Gen Psychiatry; 1992 Dec 07; 49(12):999-1000. PubMed ID: 1449388
    [No Abstract] [Full Text] [Related]

  • 20. Elevation of plasma homovanillic acid level can be detected within four hours after initiation of haloperidol treatment.
    Davila R, Zumarraga M, Perea K, Andia I, Friedhoff AJ.
    Arch Gen Psychiatry; 1987 Sep 07; 44(9):837-8. PubMed ID: 3632258
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.